JP2016014660A5 - - Google Patents

Download PDF

Info

Publication number
JP2016014660A5
JP2016014660A5 JP2015116494A JP2015116494A JP2016014660A5 JP 2016014660 A5 JP2016014660 A5 JP 2016014660A5 JP 2015116494 A JP2015116494 A JP 2015116494A JP 2015116494 A JP2015116494 A JP 2015116494A JP 2016014660 A5 JP2016014660 A5 JP 2016014660A5
Authority
JP
Japan
Prior art keywords
expression
detecting
inflammatory
inflammatory biomarkers
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015116494A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016014660A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016014660A publication Critical patent/JP2016014660A/ja
Publication of JP2016014660A5 publication Critical patent/JP2016014660A5/ja
Pending legal-status Critical Current

Links

JP2015116494A 2009-04-23 2015-06-09 免疫調節物質の同定方法及びシステム Pending JP2016014660A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17210109P 2009-04-23 2009-04-23
US61/172,101 2009-04-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012507451A Division JP2012524910A (ja) 2009-04-23 2010-04-23 免疫調節物質の同定方法及びシステム

Publications (2)

Publication Number Publication Date
JP2016014660A JP2016014660A (ja) 2016-01-28
JP2016014660A5 true JP2016014660A5 (enExample) 2016-04-28

Family

ID=42993293

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012507451A Pending JP2012524910A (ja) 2009-04-23 2010-04-23 免疫調節物質の同定方法及びシステム
JP2015116494A Pending JP2016014660A (ja) 2009-04-23 2015-06-09 免疫調節物質の同定方法及びシステム

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012507451A Pending JP2012524910A (ja) 2009-04-23 2010-04-23 免疫調節物質の同定方法及びシステム

Country Status (4)

Country Link
US (2) US20100275282A1 (enExample)
EP (1) EP2422200A4 (enExample)
JP (2) JP2012524910A (enExample)
WO (1) WO2010124256A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20090124573A1 (en) 2007-11-09 2009-05-14 Sarkis Mazmanian Immunomodulating compounds and related compositions and methods
HUE040658T2 (hu) * 2010-04-07 2019-03-28 California Inst Of Techn Vivõanyag vegyület mukózus membránhoz juttatásához és kapcsolódó készítmények, eljárások és rendszerek
WO2011146910A1 (en) 2010-05-20 2011-11-24 Round June L Antigen specific tregs and related compositions, methods and systems
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
US20130064859A1 (en) * 2011-01-28 2013-03-14 Sarkis K. Mazmanian Combinatorial vitamin d and probiotic therapy for inflammatory bowel disease
US9539281B2 (en) 2011-07-12 2017-01-10 The Brigham And Women's Hospital, Inc. Lipid-containing PSA compositions, methods of isolation and methods of use thereof
WO2013019896A1 (en) * 2011-08-01 2013-02-07 Symbiotix Biotherapies, Inc. Platform for identifying and/or characterizing immunomodulatory agents
EP2764090B1 (en) 2011-10-03 2017-12-13 California Institute of Technology Generation of psa-only producing mutant strain
CA2892588A1 (en) 2011-12-01 2013-06-06 School Corporation, Azabu Veterinary Medicine Educational Institution Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
WO2014182966A1 (en) 2013-05-10 2014-11-13 California Institute Of Technology Probiotic prevention and treatment of colon cancer
WO2016201342A1 (en) 2015-06-10 2016-12-15 California Institute Of Technology Sepsis treatment and related compositions methods and systems
CN108135167B (zh) 2015-08-19 2021-07-09 哈佛学院院长及董事 脂化psa组合物和方法
DK3347030T3 (da) 2015-09-10 2021-08-09 Univ Catholique Louvain Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
WO2018014012A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use
WO2018023088A1 (en) 2016-07-29 2018-02-01 Confer Health, Inc. Gel electrophoresis diagnostic kit and methods of using the same
CA3048210A1 (en) 2016-12-23 2018-06-28 Vital Biosciences, Inc. Electrophoresis diagnostic methods and kits
JP6836756B2 (ja) * 2017-09-21 2021-03-03 光博 岡野 口腔細菌叢中の構成叢比を予測する方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679654A (en) * 1994-09-02 1997-10-21 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
SV2003000753A (es) * 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
EP1372706B1 (en) * 2001-03-09 2010-12-01 ID Biomedical Corporation of Quebec Proteosome-liposaccharide vaccine adjuvant
JP2003204796A (ja) * 2001-11-08 2003-07-22 Japan Science & Technology Corp 非ヒト遺伝子改変動物およびその利用
US7829289B2 (en) * 2002-05-14 2010-11-09 Institut National De La Sante Et De Recherche Medicale T cell subpopulation regulating gut immunity
CA2508720A1 (en) * 2002-12-03 2004-06-17 Dartmouth College Method to measure a t cell response and its uses to qualify antigen-presenting cells
AU2004227852B2 (en) * 2003-03-31 2010-01-14 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
WO2005010215A2 (en) * 2003-07-17 2005-02-03 Tolerrx, Inc. Methods for identifying tolerance modulatory compounds and uses therefor
WO2005094571A1 (ja) * 2004-03-31 2005-10-13 Japan Science And Technology Agency 遺伝子改変ヘテロ動物及び該動物を用いたエキソサイトシスの計測方法
US8426146B2 (en) * 2005-06-03 2013-04-23 University of Pittsburgh—of the Commonwealth System of Higher Education Multiparameteric method for assessing immune system status
JP2007119414A (ja) * 2005-10-31 2007-05-17 Univ Nagoya Ｃｄ８＋ｃｄ１２２＋ｔ細胞の免疫抑制活性を増強させる免疫抑制剤
WO2007092451A2 (en) * 2006-02-06 2007-08-16 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
EP2165194A4 (en) * 2007-05-31 2010-09-08 Abbott Lab BIOMARKERS FOR PREDICTING RESPONSABILITY TO TNF ALPHA INHIBITORS IN AUTOIMMUNE DISEASES

Similar Documents

Publication Publication Date Title
Bertoletti et al. SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Root-Bernstein Innate receptor activation patterns involving TLR and NLR synergisms in COVID-19, ALI/ARDS and sepsis cytokine storms: a review and model making novel predictions and therapeutic suggestions
Kozak et al. MicroRNA and mRNA dysregulation in astrocytes infected with Zika virus
Hisamatsu et al. Immune aspects of the pathogenesis of inflammatory bowel disease
Maksimović et al. Mycoplasma ovipneumoniae: a most variable pathogen
JP2018508198A5 (enExample)
Chen et al. Lactobacillus rhamnosus GG promotes recovery of the colon barrier in septic mice through accelerating ISCs regeneration
JP2013504623A5 (enExample)
Wang et al. The regulatory T cells in anti-influenza antibody response post influenza vaccination
Authier et al. Oral administration of Lactobacillus helveticus LA401 and Lactobacillus gasseri LA806 combination attenuates oesophageal and gastrointestinal candidiasis and consequent gut inflammation in mice
Khalifa et al. Bacillus amyloliquefaciens enriched camel milk attenuated colitis symptoms in mice model
Ries et al. Isolation and cultivation of a new isolate of BTV-25 and presumptive evidence for a potential persistent infection in healthy goats
Niculita-Hirzel et al. Season, vegetation proximity and building age shape the indoor fungal communities’ composition at city-scale
Taranu et al. In vitro transcriptome response to a mixture of lactobacilli strains in intestinal porcine epithelial cell line
Ahn et al. The effect of probiotics on intestinal tight junction protein expression in animal models: a meta-analysis
Chepkwony et al. Efficacy of heterologous prime-boost vaccination with H3N2 influenza viruses in pre-immune individuals: studies in the pig model
Liu et al. Probiotic Lactobacillus johnsonii reduces intestinal inflammation and rebalances splenic Treg/Th17 responses in dextran sulfate sodium-induced colitis
Diez-Echave et al. Probiotic and functional properties of Limosilactobacillus reuteri INIA P572
Yi et al. Segmented filamentous bacteria induce divergent populations of antigen-specific CD4 T cells in the small intestine
Wang et al. Bacterial and fungal aerosols in poultry houses: PM2. 5 metagenomics via single-molecule real-time sequencing
Bacalhau et al. Laboratory tools to predict CFTR modulator therapy effectiveness and to monitor disease severity in cystic fibrosis
Gozalbo-Rovira et al. Microbiota depletion promotes human rotavirus replication in an adult mouse model
Rattan et al. Development of a mouse model to explore CD4 T cell specificity, phenotype, and recruitment to the lung after influenza b infection
Li et al. Diagnosis of a Rabbit Hemorrhagic Disease Virus 2 (RHDV2) and the humoral immune protection effect of VP60 vaccine
Chen et al. Lactobacillus murinus reduces susceptibility to secondary MRSA infection in IAV-infected mice through promoting a T cell-independent IgA response